Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes

Clinical Cardiology

Volumn 23, Issue 9, 2000, Pages 697-700

  Gurfinkel, Enrique P ^a   Altman, Raul ^a   Scazziota, Alejandra ^a   Heguilen, Ricardo ^b   Mautner, Branco ^c  

^a Ctro Estud Medicos y Bioquimicos   (Argentina)

^b Investigaciones Clínicas   (Argentina)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

Angina; Aspirin; Atherosclerosis; Lysine acetylsalicylate; Platelet inhibition; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; COLLAGEN; LYSINE ACETYLSALICYLATE;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DRUG EFFICACY; FEMALE; FIBRINOLYSIS; HEART MUSCLE ISCHEMIA; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0033795540     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960230912     Document Type: Article

References (16)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
2. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients
3. The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction
4. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
5. Multiple doses of regular and enteric-coated aspirin produce equivalent platelet inhibitory effects
6. Cumulative antiplatelet effect of low-dose enteric-coated aspirin
7. Effect de 2 doses d'acetylsalicylate de lysine sur l'agregation plaquettaire, la β-thromboglobuline et le facteur plaquettaire 4 chez des sujets ages atherosclereux
8. Comparison of IM lysine acetylsalicylate and oxycodone in the treatment of pain after operation
9. Route of administration and sex differences in the pharmacokinetics of aspirin, administered as its lysine salt
10. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
11. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects
12. Equal antiplatelet effects of aspirin 50 or 324 mg/day in patients after acute myocardial infarction
13. Low-dose aspirin in patients recovering from myocardial infarction: Evidence for selective inhibition of thromboxane-related platelet function
14. Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men
15. Pharmacokinetics of salicylic acid following administration of aspirin tablets and three different forms of soluble aspirin in normal subjects
16. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase